Aquila Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,000
| Closed | -$448K | – | 65 |
|
|
2024
Q1 | $448K | Hold |
3,000
| – | – | 0.38% | 63 |
|
|
2023
Q4 | $574K | Buy |
3,000
+1,000
| +50% | +$191K | 0.5% | 72 |
|
|
2023
Q3 | $354K | Hold |
2,000
| – | – | 0.33% | 81 |
|
|
2023
Q2 | $380K | Hold |
2,000
| – | – | 0.31% | 86 |
|
|
2023
Q1 | $401K | Hold |
2,000
| – | – | 0.33% | 82 |
|
|
2022
Q4 | $475K | Hold |
2,000
| – | – | 0.37% | 85 |
|
|
2022
Q3 | $400K | Buy |
+2,000
| New | +$400K | 0.3% | 88 |
|